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Benign Strictures of the Esophagus and
Gastric Outlet: Interventional
Management
Benign strictures of the esophagus and gastric outlet are difficult to manage
conservatively and they usually require intervention to relieve dysphagia or to
treat the stricture-related complications. In this article, authors review the non-sur-
gical options that are used to treat benign strictures of the esophagus and gastric
outlet, including balloon dilation, temporary stent placement, intralesional steroid
injection and incisional therapy. 
t is not uncommon to encounter benign strictures of the esophagus and
gastric outlet in clinical practice (1-4). Any benign process that obstructs
the esophagus or stomach, or that induces inflammatory or fibrotic
changes in the esophagus or stomach can result in esophageal strictures and gastric
outlet obstruction (1-8). These benign strictures can have a major negative impact on a
patient’s well-being, and the complications include malnutrition, aspiration, pain and
respiratory failure (9-11). These strictures are difficult to manage conservatively and
they usually require intervention to relieve the dysphagia or to treat the stricture-
related complications (12-14). Although the surgical procedures are potentially
curative, they are associated with high rates of morbidity and mortality (15-17).
Several non-surgical, minimally invasive options are available to treat benign
strictures of the esophagus and gastric outlet. These procedures, which can be
performed endoscopically or fluoroscopically, include balloon dilation, temporary
stent placement, intralesional steroid injection and incisional therapy. This article
reviews the use of these options to treat benign strictures of the esophagus and gastric
outlet.
Benign Esophageal Strictures
Benign esophageal strictures are sequelae of deep esophageal injuries, and these
injuries may be due to peptic ulcer disease, surgery, radiation therapy, Schatzki’s ring,
esophageal webs and corrosive injury (6). These injuries stimulate the overproduction
of fibrotic tissue and this leads to the formation of benign esophageal strictures (18).
These strictures can be divided into two categories, 1) simple and 2) complex, based
on their length, shape and diameter. Simple esophageal strictures are defined as those
that are focal and straight, with most having a diameter that allows the passage of an
endoscope of normal diameter (3). Simple strictures are usually caused by peptic ulcer
disease, Schatzki’s ring or a web (3, 19). Complex esophageal strictures are defined as
those that are long (> 2 cm), tortuous or that have a diameter that prevents passage of
an endoscope of normal diameter (3). The most common causes of complex strictures
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Iinclude corrosive injury, radiation, anastomotic stricture
and severe peptic injury (6, 14, 20, 21).
Balloon Dilation
Balloon dilation under endoscopic or fluoroscopic
guidance is regarded as a safe, effective initial option for
treating benign esophageal strictures (1, 3, 4, 12, 14, 15,
19, 22). Balloon dilation is thought to widen the luminal
diameter of the esophagus by circumferential stretching
and/or splitting of the stricture (1, 3). Under endoscopic or
fluoroscopic guidance, the middle portion of the balloon is
positioned at the narrowest part of the stricture and then it
is inflated with water or contrast medium until the waist
deformity created by the stricture disappears from the
balloon contour or until the patient develops severe pain
(1, 4). Elimination of the waist is an indicator of successful
dilation. The balloon’s diameter should be progressively
increased, with starting by performing dilation with a small
balloon and progressing to larger sizes to minimize the
chance of perforation (4). The first balloon is often 10-15
mm in diameter; if dilation with this sized balloon is easily
accomplished and the patient well tolerates the procedure,
then the diameter of the balloon catheter is increased up to
20-25 mm. If at any point the patient complains of intoler-
able pain or if a persistent waist remains in the balloon
even at the maximal inflation pressure (i.e., 6 atm), then
the dilation should be stopped (23). Fluoroscopy allows
complete visual control and so it may help minimize the
risk of perforation due to inappropriate advancement of
instruments and misplacement of the balloon, which can be
caused by sliding during inflation, and especially when
treating complex strictures (1, 4).
Simple esophageal strictures generally respond well to
balloon dilation. Most patients with simple esophageal
strictures require 1-3 dilations to relieve their symptoms,
although 25-35% of patients require repeated dilations
(13). Yet complex esophageal strictures are more difficult
to treat, and they require at least three dilation sessions to
relieve the obstructive symptoms, and complex esophageal
strictures are associated with high rates of recurrence and
perforation (6, 14). For example, 43-46% of patients
require repeated balloon dilations for esophageal strictures
induced by radiation injury (20, 24) (Fig. 1). Although they
are minor complications, type 1 (intramural) and type 2
(transmural without mediastinal spillage) esophageal
ruptures were observed after 12 of 25 (48%) balloon
dilations for esophageal strictures caused by radiation
injury (20). Moreover, 62% (73 of 117) of patients with
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Fig. 1. Radiation-induced esophageal stricture. 
A. Esophagogram shows 5-cm long stricture (arrow) in mid-esophageal area. 
B. Dilation of stricture using 15-mm-diameter balloon under fluoroscopic guidance. Because dilation was not easily accomplished, caliber
of balloon catheter was not increased to 20 mm. 
C. Esophagogram one month after balloon dilation shows improvement of stricture (arrow). Patient’s symptoms were also resolved, but
symptoms recurred two months later. 
ABCcorrosive esophageal strictures required repeated balloon
dilations owing to recurrence. In addition, esophageal
ruptures occurred after 52 of 390 balloon dilations (13%),
including 35 type 1, 14 type 2 and three type 3 (transmural
with mediastinal spillage) ruptures.
The patients with type 1 and type 2 esophageal ruptures
can be managed conservatively. Those patients with type 2
esophageal rupture and who experience persistent extralu-
minal leakage, even after conservative treatment, can be
treated by insertion of a covered stent to prevent leakage
(25). Surgery is indicated for the patients with type 3
esophageal rupture and for patients with progressive
clinical deterioration (26).
Refractory benign esophageal strictures are defined as
those that cannot be dilated to an adequate diameter, those
that recur within a short time interval or those that require
continuous dilation (27). These resistant strictures may
seriously affect a patient’s quality of life owing to compli-
cations such as aspiration, malnutrition, pain and
esophageal perforation (10). Among the methods used to
treat refractory benign esophageal strictures are intrale-
sional steroid injection, temporary stenting and incisional
therapy. 
Intralesional Steroid Injection
The intralesional injection of corticosteroids has been
reported to soften scars and keloids (28, 29) owing to the
local inhibition of inflammatory responses, which results in
the reduction of fibrotic tissue (30). Intralesional steroid
injections have been increasingly used over the past
decade to treat refractory benign esophageal strictures
(30-32). This approach usually involves endoscopic intrale-
sional injections of triamcinolone acetonide (40 mg/mL,
diluted 1:1 with saline solution) into all four quadrants of
the strictures, and this is most often done in combination
with balloon dilation (30-32). The combination of intrale-
sional steroid injection and balloon dilation has been
shown to increase the intervals between dilations and to
decrease their frequency (30-32). However, this therapy
seems to be inadequate to treat long strictures.
Furthermore, the optimal injection technique and the
frequency and dose of triamcinolone injections have not
yet been established (1).
Stent Placement
Stent placement is a commonly used, minimally invasive
method to treatment unresectable malignant strictures and
fistulas (33, 34). However, permanent stenting of benign
esophageal strictures in patients with a relatively long life
expectancy has not yet reached widespread acceptance
owing to the late adverse events of stent placement,
including the development of new strictures caused by
stent-induced granulation tissue, stent migration and
esophageal ulceration (35, 36). However, temporary
placement of retrievable, fully covered stents made of
plastic or metal has become a new strategy for treating
refractory benign esophageal strictures (10, 11, 37-39)
(Fig. 2). The therapeutic concept of temporary stenting is
quite attractive because a stent has a persistent dilation
effect after placement and it can be removed after the
stricture heals or when new strictures or other stent-related
complications occur. The early experience of temporary
stenting for refractory benign esophageal stricture was
favorable (18, 37). In one series (37), 17 of 21 patients
(81%) showed improvement of dysphagia after a median
of 21 months with no complications. In another series (18),
12 of 15 patients (80%) showed improvement of dyspha-
gia after a median of 22.7 months. However, five patients
(33%) showed recurrent symptoms, four due to formation
of granulation tissue and one due to stent migration (18). 
Yet more recent studies have found that the rates of
long-term resolution of dysphagia after temporary stenting
were unsatisfactory, with high rates of complications (10,
11, 38). For example, one study (11) found that only 31%
of patients showed long-term relief of symptoms, whereas
the rates of complications were high, including the rates of
stent migration (62%), pain (27%) and stent-induced
formation of granulation tissue (17%). Another study (38)
found that only 30% of patients (intention to treat) were
dysphagia-free after a median follow-up of 12.3 months,
with high rates of complications, including stent migration
(22%), severe chest pain (11%), bleeding (8%), perfora-
tion (6%), gastroesophageal reflux (6%), impaction (6%)
and new fistula (3%), and one patient died of massive
bleeding. 
A third study (10) also showed that temporary metallic
stenting for refractory benign esophageal strictures
achieved discouraging results. During a mean follow-up
period of 38 months, only 31% of patients showed long-
term relief of obstructive symptoms. The most common
complications were granulation tissue formation (31%),
severe pain (24%) and stent migration (25%). The rates of
maintained patency after temporary metallic stenting at 1,
3 and 6 months and 1, 2 and 4 years were 58%, 43%,
38%, 33%, 26% and 21%, respectively (10). An increased
stricture length was found to be a significant predictor of
stricture recurrence (10).
Temporary stenting does have several benefits. For
example, temporary stent placement should be considered
during the early chronic stage (3 weeks to 6 months after
ingestion of a corrosive agent) for patients with corrosive
strictures because these patients are highly prone to
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temporary stent placement can serve as an effective bridge
to surgery for patients who require a considerable time
before surgery. Furthermore, stent placement may be the
only option for patients with severe stenosis that prevents
adequate balloon dilation.  
Efforts are underway to decrease the rates of stent-
related complications, including formation of granulation
tissue and stent migration. An in vivo animal study showed
that compared with conventional metallic stents, drug-
eluting (paclitaxel) stents induced little tissue reaction
around the esophageal mucosa, and the drug-eluting
(paclitaxel) stents were easily separated from esophageal
tissue, which allows easy retrievability (40). In addition, a
new esophageal stent has been developed with an anti-
migration design, a double-layer configuration (inner
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Fig. 2. Corrosive esophageal stricture. 
A. Esophagogram shows focal stricture
(arrow) at distal esophageal level.
B. Severe tight stricture precluded dilation
with 10-mm-diameter balloon.
C. Placement of retrievable covered metallic
stent (arrowheads) at stricture.
D. Esophagogram immediately after stent
placement shows good contrast passage
through stent.
E. Esophagogram five years after
temporary stenting for two months shows
stricture improvement was maintained
(arrow). 
ABC
DEcovered and outer uncovered parts) and an outer
uncovered nitinol wire tube, which allows the stent to fix
itself in the esophageal wall (41). These new stents
provided good symptom relief with low rates of recurrent
dysphagia and stent migration (41). Because recurrent
dysphagia is often due to the formulation of granulation
tissue and stent migration, drug-eluting or anti-migration
stents may be a good alternative in the management of
refractory benign esophageal strictures. 
In summary, temporary stenting for refractory benign
esophageal strictures may be effective during the period of
stent placement. Yet following stent removal, the
symptom-free period rapidly decreases over time, and
particularly in patients with long strictures. Temporary
stenting is associated with high complication rates and so it
should only be considered in carefully selected patients. 
Incisional Therapy
Incisional therapy using electrocautery, with or without
argon plasma coagulation or endoscopic scissors, has been
successful in patients with Schatzki’s rings or circular
anastomotic strictures that are refractory to dilations (42-
44). For instance, evaluation of the efficacy of electro-
cautery needle-knife treatment in 20 patients with refrac-
tory anastomotic strictures of the esophagus showed that
12 patients with strictures < 1 cm remained dysphagia-free
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Fig. 3. Peptic ulcer-induced duodenal stricture.
A. Upper gastrointestinal series shows peptic ulcer-induced stricture (arrow) in second portion of duodenum. 
B-E. Under fluoroscopic guidance, stricture was initially dilated with 8-mm-diameter balloon. Because dilation was easily achieved,
caliber of balloon catheter was increased to 15 mm.
F. Upper gastrointestinal series one year after balloon dilation shows improvement of luminal diameter (arrow).
DEFfor 12 months after a single treatment (42). In contrast,
dysphagia recurred in eight patients who had long-segment
strictures (1.5-5 cm), and these patients required a mean of
three treatments (42). 
Incisional therapy has been also used as the primary
treatment for patients with Schatzki’s rings and anasto-
motic strictures after gastroesophageal surgery (8, 9). For
example, a randomized, prospective trial that compared
electrosurgical incision combined with acid suppression
treatment and bougie dilation combined with acid suppres-
sion treatment in 25 patients with symptomatic Schatzki’s
rings found that the symptom-free period was significantly
longer in the incision group than in the bougie dilation
group (7.99 vs. 5.86 months, p = 0.03) and that the
addition of acid suppression treatment reduced the gastroe-
sophageal reflux-related symptoms, regardless of the
primary treatment (8).
In summary, incisional therapy may be a good alterna-
tive for the treatment of resistant or non-resistant anasto-
motic strictures of the esophagus and Schatzki’s ring.
However, incisional therapy is not appropriate for patients
with long esophageal strictures.
Benign Gastric Outlet Strictures
Benign strictures of the gastric outlet are not uncommon
in clinical practice and these may have several etiologies,
including anastomotic strictures after gastric surgery, peptic
ulcer, corrosive injury, strictures secondary to intervention,
and rarely, Crohn’s disease (2, 4, 5, 7, 15, 16, 45). These
strictures may result in prolonged vomiting and nutritional
deficiencies (46). Surgical revision is indicated for the
patients with benign gastric outlet strictures and who do
not respond to conservative medical treatment (47, 48).
However, surgery is associated with high rates of morbid-
ity and mortality, and particularly in patients with high risk
factors, including an advanced age, a poor nutritional
status or combined disease (49). 
Balloon Dilation
Endoscopically or fluoroscopically guided balloon
dilation is a safe and effective alternative to surgery for
patients with benign strictures of the gastric outlet (2, 4, 5,
7, 15, 16, 45). It is considered to be a more rapid treatment
and more cost effective than surgery.
Balloon dilation has been widely used for treating
patients with peptic ulcer-related gastric outlet obstruction
(Fig. 3), but the long-term outcomes were found to widely
vary, from 16-100% (50-53). Yet more recently, balloon
dilation combined with antisecretory therapy and removal
of the etiologic factors (e.g., Helicobacter pylori) was
shown to achieve long-term resolution of symptoms in 85-
100% of patients with peptic ulcer-related gastric outlet
obstruction (2, 54). 
Benign anastomotic strictures occur in 3-13% of patients
after gastric surgery, and usually within the first three
months (7, 55). Obesity has become a major health
problem, leading to an increase in performing restrictive
gastric surgery for morbidly obese patients worldwide.
Several studies have assessed the efficacy of balloon
dilation for treating benign gastric outlet stricture after
restrictive surgery for morbid obesity (7, 16, 55, 56). For
example, one or two endoscopic balloon dilations resulted
in symptom resolution without any major complications in
93% (40 of 43) of patients with gastrojejunostomy
strictures after Roux-en-Y gastric bypass for obesity during
the first year. In addition, fluoroscopically guided balloon
dilation relieved the obstructive symptoms in 50% (12 of
24) of the patients who had gastric outlet strictures after
surgery for morbid obesity after a mean follow-up of 29
months (16). Fluoroscopically guided balloon dilation also
led to symptom resolution in 16 of 17 (84%) patients who
were treated for benign strictures that were caused by
Billroth I (gastroduodenostomy) or Billroth II (gastroje-
junostomy) reconstruction for malignancy or gastric ulcer,
with no major complications, over a mean of 14 months
(57). An interval of two or three weeks has been suggested
as the minimum ‘safe’ time between surgery and dilation of
an anastomotic stricture (21, 58). 
Gastric outlet stricture can also result from the ingestion
of caustic substances. However, only six of 17 (35%)
patients with caustic strictures responded to balloon
dilation, compared with a 70% response rate for the
patients with peptic strictures (52). Furthermore, the
patients with caustic strictures required more dilations than
those with peptic ulcer-related strictures (53). Yet more
recently, repeated balloon dilations (mean: 5.8 sessions)
were found to achieve long-term resolution (symptom free
for 18 to 58 months) in 95% (39 of 41) of the patients with
short-segment (< 2.5 cm), caustic-induced gastric outlet
strictures (5).
Strictures occurring at the gastric outlet should be
sufficiently dilated to prevent symptoms of obstruction,
but not so much as to increase the risk of perforation.
Thus, it is important to determine the optimal diameter of
dilation. The optimal diameter may depend on the type of
stricture (i.e., anastomotic vs. non-anastomotic stricture).
For anastomotic strictures, a diameter of 20 mm may
prevent symptoms of obstruction with no major complica-
tions (57). Yet for non-anastomotic strictures, a maximal
diameter of 15 mm may be sufficient to relieve obstructive
symptoms (2, 5). Balloons of larger diameter (> 15 mm)
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of non-anastomotic strictures. For example, dilation with
20-mm balloons caused perforations in two of three
patients with peptic pyloric strictures (51), and dilations to
18 mm caused perforations in two patients with peptic
pyloroduodenal strictures (59). Following laparotomy,
21% of the patients with gastric outlet strictures and who
were dilated to 20 mm experienced perforations,
compared with none of those patients whose strictures
were dilated to 15 mm (60-62). 
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Fig. 4. Benign anastomotic stricture at gastroduodenostomy.
A, B. Endoscopic image (arrowhead) and upper gastrointestinal
series (arrow) show severe anastomotic stricture upon gastroduo-
denostomy.
C. Because stricture was resistant to repeated balloon dilation,
retrievable covered metallic stent (arrow) was inserted.
D, E. Three months after stent placement, stent was endoscopi-
cally removed using rat-tooth forceps (arrowhead). Endoscopic
image immediately after stent removal showed improvement of
stricture (arrowheads).
EOther Options
Severely angulated, tortuous or edematous benign
gastric outlet strictures are usually refractory to balloon
dilation (21, 56, 57). Resistance to initial balloon dilation
may result in poor long-term results, and early surgical
revision has been recommended for these patients (63, 64),
but several non-surgical options are available to treat these
strictures.
Metallic stents are safe and effective for patients with
malignant gastric outlet obstruction (65, 66) and metallic
stents have been used in selected patients with benign
gastric outlet strictures that are refractory to balloon
dilation (Fig. 4). For example, temporary placement of a
covered retrievable metallic stent for two months to treat a
patient with a benign anastomotic duodenojejunal stricture
that was resistant to repeated balloon dilations resulted in
a favorable outcome at up to six months after stent
removal (67). Stent placement in seven patients with
resistant benign anastomotic strictures after gastric surgery
showed benefit for five patients (71%), regardless of
whether the stent placement was temporary (two patients)
or permanent (three patients) (21). However, owing to the
high risk of migration, stents should be used only in
selected patients with resistant benign gastric outlet
strictures (21). 
Electrosurgical incision, with or without balloon dilation,
has been successful in a small numbers of patients (< 5)
with refractory benign gastric outlet strictures (68, 69). In
addition, intralesional steroid injections have been used to
augment the effect of balloon dilation in three patients
with corrosive-induced pyloric stenosis (70).
Summary
Balloon dilation is a safe, effective initial option in the
treatment of benign strictures of the esophagus and gastric
outlet. Intralesional steroid therapy, electrosurgical incision
or stent placement can be effective in selected patients
with strictures that are resistant to balloon dilation.
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